Menu

Unity Biotechnology, Inc. UBX

Full chart Compare
Set alert

Price alert · UBX

All alert types
0.20 0.00 (+0.00%)

At closeJul 2, 2026, 4:00 PM EDT

0.2001 Day range 0.2001
0.20 52-week range 3.10
YTD
-79.51%
1 year
-84.95%

Revenue & Expenses

Other Income → Expenses: $16.66MExpenses → Selling, General & Admin: $20.95MExpenses → Research & Development: $36.86MExpenses → Interest Expense: $3.56MGross Profit → Expenses: $236.00KRevenue → Gross Profit: $236.00KNet Loss → Expenses: $44.47MOther Income$16.66MGross Profit$236.00KNet Loss$44.47MExpenses$61.37MSelling, General & Admin$20.95MResearch & Development$36.86MInterest Expense$3.56MRevenue$236.00K

Latest period ending Dec 31, 2024 · select a line to chart its full history

UBX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-31.17M-44.67M-57.57M-56.66M-93.93M
-25.99M-39.86M-44.47M-60.73M-93.84M
-1.54-2.70-4.68-10.88-18.45
UBX annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
7.58M19.80M12.74M33.45M17.81M
37.66M65.69M124.35M124.71M156.32M
31.17M37.29M68.27M65.14M73.44M
19.71M23.54M47.36M52.52M58.98M
6.49M28.40M56.08M59.57M82.88M
UBX annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-20.86M-37.09M-52.41M-45.06M-78.33M
8.56M60.49M-24.55M39.31M-5.21M
77.00K-16.34M56.24M20.84M63.88M
26.00K104.00K282.00K-195.00K-646.00K
-12.22M7.07M-20.72M15.10M-19.67M